nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ADRA2A—type 2 diabetes mellitus	0.0965	0.288	CbGaD
Olanzapine—HTR2C—type 2 diabetes mellitus	0.0889	0.265	CbGaD
Olanzapine—CYP1A2—type 2 diabetes mellitus	0.0671	0.2	CbGaD
Olanzapine—CYP3A4—type 2 diabetes mellitus	0.0444	0.132	CbGaD
Olanzapine—ALB—type 2 diabetes mellitus	0.0387	0.115	CbGaD
Olanzapine—DRD5—Bromocriptine—type 2 diabetes mellitus	0.0285	0.0551	CbGbCtD
Olanzapine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0209	0.0404	CbGbCtD
Olanzapine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0203	0.0393	CbGbCtD
Olanzapine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0183	0.0354	CbGbCtD
Olanzapine—ORM1—Nateglinide—type 2 diabetes mellitus	0.017	0.0328	CbGbCtD
Olanzapine—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0167	0.0323	CbGbCtD
Olanzapine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0163	0.0316	CbGbCtD
Olanzapine—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.016	0.031	CbGbCtD
Olanzapine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0151	0.0292	CbGbCtD
Olanzapine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0145	0.0281	CbGbCtD
Olanzapine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0145	0.0281	CbGbCtD
Olanzapine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0138	0.0267	CbGbCtD
Olanzapine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0117	0.0226	CbGbCtD
Olanzapine—ALB—Gliclazide—type 2 diabetes mellitus	0.0111	0.0214	CbGbCtD
Olanzapine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0106	0.0206	CbGbCtD
Olanzapine—ALB—Repaglinide—type 2 diabetes mellitus	0.0104	0.0202	CbGbCtD
Olanzapine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.01	0.0194	CbGbCtD
Olanzapine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.00959	0.0186	CbGbCtD
Olanzapine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.00959	0.0186	CbGbCtD
Olanzapine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0092	0.0178	CbGbCtD
Olanzapine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.00883	0.0171	CbGbCtD
Olanzapine—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00869	0.0168	CbGbCtD
Olanzapine—ALB—Valsartan—type 2 diabetes mellitus	0.00768	0.0149	CbGbCtD
Olanzapine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00765	0.0148	CbGbCtD
Olanzapine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00718	0.0139	CbGbCtD
Olanzapine—ALB—Nateglinide—type 2 diabetes mellitus	0.00714	0.0138	CbGbCtD
Olanzapine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00702	0.0136	CbGbCtD
Olanzapine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00681	0.0132	CbGbCtD
Olanzapine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00642	0.0124	CbGbCtD
Olanzapine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00611	0.0118	CbGbCtD
Olanzapine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00611	0.0118	CbGbCtD
Olanzapine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00597	0.0116	CbGbCtD
Olanzapine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00564	0.0109	CbGbCtD
Olanzapine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00544	0.0105	CbGbCtD
Olanzapine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0052	0.0101	CbGbCtD
Olanzapine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00508	0.00982	CbGbCtD
Olanzapine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00508	0.00982	CbGbCtD
Olanzapine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00493	0.00953	CbGbCtD
Olanzapine—ALB—Glyburide—type 2 diabetes mellitus	0.00482	0.00933	CbGbCtD
Olanzapine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00469	0.00907	CbGbCtD
Olanzapine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00464	0.00898	CbGbCtD
Olanzapine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00458	0.00886	CbGbCtD
Olanzapine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00452	0.00876	CbGbCtD
Olanzapine—ALB—Losartan—type 2 diabetes mellitus	0.00441	0.00853	CbGbCtD
Olanzapine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00428	0.00829	CbGbCtD
Olanzapine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00414	0.00801	CbGbCtD
Olanzapine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00409	0.00792	CbGbCtD
Olanzapine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00408	0.0079	CbGbCtD
Olanzapine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00387	0.00749	CbGbCtD
Olanzapine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00385	0.00745	CbGbCtD
Olanzapine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00373	0.00723	CbGbCtD
Olanzapine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00369	0.00714	CbGbCtD
Olanzapine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00352	0.00681	CbGbCtD
Olanzapine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00339	0.00655	CbGbCtD
Olanzapine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00337	0.00653	CbGbCtD
Olanzapine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00326	0.00632	CbGbCtD
Olanzapine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00313	0.00605	CbGbCtD
Olanzapine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00295	0.00571	CbGbCtD
Olanzapine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00286	0.00553	CbGbCtD
Olanzapine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00264	0.0051	CbGbCtD
Olanzapine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0026	0.00503	CbGbCtD
Olanzapine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00252	0.00488	CbGbCtD
Olanzapine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00238	0.0046	CbGbCtD
Olanzapine—ABCB1—Losartan—type 2 diabetes mellitus	0.00231	0.00446	CbGbCtD
Olanzapine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00224	0.00433	CbGbCtD
Olanzapine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00214	0.00415	CbGbCtD
Olanzapine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00214	0.00415	CbGbCtD
Olanzapine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00203	0.00392	CbGbCtD
Olanzapine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00176	0.0555	CbGeAlD
Olanzapine—HTR2A—arteriole—type 2 diabetes mellitus	0.00173	0.0543	CbGeAlD
Olanzapine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00151	0.00292	CbGbCtD
Olanzapine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00138	0.00267	CbGbCtD
Olanzapine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00119	0.0373	CbGeAlD
Olanzapine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0011	0.0346	CbGeAlD
Olanzapine—DRD1—nerve—type 2 diabetes mellitus	0.00107	0.0336	CbGeAlD
Olanzapine—HTR3A—nerve—type 2 diabetes mellitus	0.00103	0.0324	CbGeAlD
Olanzapine—HTR1B—artery—type 2 diabetes mellitus	0.000872	0.0274	CbGeAlD
Olanzapine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000855	0.0269	CbGeAlD
Olanzapine—HTR1D—artery—type 2 diabetes mellitus	0.000844	0.0266	CbGeAlD
Olanzapine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000739	0.0233	CbGeAlD
Olanzapine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000684	0.0215	CbGeAlD
Olanzapine—HTR7—artery—type 2 diabetes mellitus	0.000672	0.0211	CbGeAlD
Olanzapine—HTR7—nerve—type 2 diabetes mellitus	0.000667	0.021	CbGeAlD
Olanzapine—DRD2—nerve—type 2 diabetes mellitus	0.00063	0.0198	CbGeAlD
Olanzapine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000627	0.0197	CbGeAlD
Olanzapine—HTR7—endothelium—type 2 diabetes mellitus	0.000568	0.0179	CbGeAlD
Olanzapine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000533	0.0168	CbGeAlD
Olanzapine—H1F0—islet of Langerhans—type 2 diabetes mellitus	0.000523	0.0165	CbGeAlD
Olanzapine—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000499	0.0157	CbGeAlD
Olanzapine—HRH2—cardiovascular system—type 2 diabetes mellitus	0.000459	0.0145	CbGeAlD
Olanzapine—FMO3—adipose tissue—type 2 diabetes mellitus	0.000455	0.0143	CbGeAlD
Olanzapine—H1F0—retina—type 2 diabetes mellitus	0.000447	0.0141	CbGeAlD
Olanzapine—H1F0—nephron tubule—type 2 diabetes mellitus	0.000421	0.0133	CbGeAlD
Olanzapine—HTR2A—artery—type 2 diabetes mellitus	0.000419	0.0132	CbGeAlD
Olanzapine—HTR2A—nerve—type 2 diabetes mellitus	0.000416	0.0131	CbGeAlD
Olanzapine—ADRA1B—kidney—type 2 diabetes mellitus	0.000392	0.0123	CbGeAlD
Olanzapine—H1F0—cardiovascular system—type 2 diabetes mellitus	0.000379	0.0119	CbGeAlD
Olanzapine—H1F0—kidney—type 2 diabetes mellitus	0.00037	0.0117	CbGeAlD
Olanzapine—H1F0—pancreas—type 2 diabetes mellitus	0.000368	0.0116	CbGeAlD
Olanzapine—H1F0—cortex of kidney—type 2 diabetes mellitus	0.000361	0.0114	CbGeAlD
Olanzapine—HTR2A—endothelium—type 2 diabetes mellitus	0.000354	0.0111	CbGeAlD
Olanzapine—H1F0—adipose tissue—type 2 diabetes mellitus	0.000334	0.0105	CbGeAlD
Olanzapine—FMO3—liver—type 2 diabetes mellitus	0.000319	0.01	CbGeAlD
Olanzapine—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000303	0.00953	CbGeAlD
Olanzapine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000301	0.00948	CbGeAlD
Olanzapine—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000293	0.00923	CbGeAlD
Olanzapine—HTR1D—kidney—type 2 diabetes mellitus	0.000287	0.00903	CbGeAlD
Olanzapine—HRH2—liver—type 2 diabetes mellitus	0.000284	0.00894	CbGeAlD
Olanzapine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000274	0.00863	CbGeAlD
Olanzapine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000273	0.00858	CbGeAlD
Olanzapine—DRD2—retina—type 2 diabetes mellitus	0.000261	0.00821	CbGeAlD
Olanzapine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.00026	0.00818	CbGeAlD
Olanzapine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000244	0.00769	CbGeAlD
Olanzapine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000241	0.00757	CbGeAlD
Olanzapine—CHRM3—kidney—type 2 diabetes mellitus	0.00024	0.00756	CbGeAlD
Olanzapine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000239	0.00752	CbGeAlD
Olanzapine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000237	0.00745	CbGeAlD
Olanzapine—H1F0—liver—type 2 diabetes mellitus	0.000234	0.00737	CbGeAlD
Olanzapine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000234	0.00735	CbGeAlD
Olanzapine—HTR7—kidney—type 2 diabetes mellitus	0.000229	0.00719	CbGeAlD
Olanzapine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000225	0.00709	CbGeAlD
Olanzapine—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000216	0.00681	CbGeAlD
Olanzapine—ADRA2C—kidney—type 2 diabetes mellitus	0.00021	0.00661	CbGeAlD
Olanzapine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000209	0.00657	CbGeAlD
Olanzapine—Amoxapine—ADRA2A—type 2 diabetes mellitus	0.000208	0.129	CrCbGaD
Olanzapine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000205	0.00644	CbGeAlD
Olanzapine—ORM1—liver—type 2 diabetes mellitus	0.0002	0.00629	CbGeAlD
Olanzapine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000199	0.00625	CbGeAlD
Olanzapine—Amoxapine—HTR2C—type 2 diabetes mellitus	0.000191	0.119	CrCbGaD
Olanzapine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000189	0.00596	CbGeAlD
Olanzapine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000177	0.00556	CbGeAlD
Olanzapine—ALB—liver—type 2 diabetes mellitus	0.000175	0.00551	CbGeAlD
Olanzapine—HTR2A—retina—type 2 diabetes mellitus	0.000172	0.00542	CbGeAlD
Olanzapine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000166	0.00524	CbGeAlD
Olanzapine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000163	0.00514	CbGeAlD
Olanzapine—Loxapine—ADRA2A—type 2 diabetes mellitus	0.000162	0.101	CrCbGaD
Olanzapine—Quetiapine—ADRA2A—type 2 diabetes mellitus	0.000158	0.0986	CrCbGaD
Olanzapine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000154	0.00484	CbGeAlD
Olanzapine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000151	0.00475	CbGeAlD
Olanzapine—Loxapine—HTR2C—type 2 diabetes mellitus	0.000149	0.093	CrCbGaD
Olanzapine—Quetiapine—HTR2C—type 2 diabetes mellitus	0.000146	0.0908	CrCbGaD
Olanzapine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000146	0.00458	CbGeAlD
Olanzapine—HTR7—liver—type 2 diabetes mellitus	0.000144	0.00455	CbGeAlD
Olanzapine—HTR2A—kidney—type 2 diabetes mellitus	0.000143	0.00448	CbGeAlD
Olanzapine—CYP2C19—liver—type 2 diabetes mellitus	0.000141	0.00444	CbGeAlD
Olanzapine—ADRA1A—liver—type 2 diabetes mellitus	0.000139	0.00438	CbGeAlD
Olanzapine—Clozapine—ADRA2A—type 2 diabetes mellitus	0.000136	0.0848	CrCbGaD
Olanzapine—ADRA2C—liver—type 2 diabetes mellitus	0.000133	0.00418	CbGeAlD
Olanzapine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000132	0.00415	CbGeAlD
Olanzapine—CYP3A4—kidney—type 2 diabetes mellitus	0.000132	0.00415	CbGeAlD
Olanzapine—CYP2D6—kidney—type 2 diabetes mellitus	0.00013	0.00409	CbGeAlD
Olanzapine—Clozapine—HTR2C—type 2 diabetes mellitus	0.000125	0.0781	CrCbGaD
Olanzapine—CYP1A2—liver—type 2 diabetes mellitus	0.000115	0.00363	CbGeAlD
Olanzapine—ABCB1—retina—type 2 diabetes mellitus	0.000113	0.00355	CbGeAlD
Olanzapine—CYP2C9—liver—type 2 diabetes mellitus	0.000109	0.00344	CbGeAlD
Olanzapine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000106	0.00334	CbGeAlD
Olanzapine—Clozapine—CYP2E1—type 2 diabetes mellitus	9.94e-05	0.0619	CrCbGaD
Olanzapine—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.54e-05	0.003	CbGeAlD
Olanzapine—Clozapine—CYP1A2—type 2 diabetes mellitus	9.46e-05	0.0589	CrCbGaD
Olanzapine—ABCB1—kidney—type 2 diabetes mellitus	9.34e-05	0.00294	CbGeAlD
Olanzapine—ABCB1—pancreas—type 2 diabetes mellitus	9.28e-05	0.00292	CbGeAlD
Olanzapine—ABCB1—cortex of kidney—type 2 diabetes mellitus	9.1e-05	0.00286	CbGeAlD
Olanzapine—HTR2A—liver—type 2 diabetes mellitus	9.01e-05	0.00283	CbGeAlD
Olanzapine—ABCB1—adipose tissue—type 2 diabetes mellitus	8.42e-05	0.00265	CbGeAlD
Olanzapine—CYP3A4—liver—type 2 diabetes mellitus	8.34e-05	0.00262	CbGeAlD
Olanzapine—CYP2D6—liver—type 2 diabetes mellitus	8.21e-05	0.00258	CbGeAlD
Olanzapine—Quetiapine—CYP3A4—type 2 diabetes mellitus	7.28e-05	0.0453	CrCbGaD
Olanzapine—Clozapine—CYP3A4—type 2 diabetes mellitus	6.26e-05	0.039	CrCbGaD
Olanzapine—ABCB1—liver—type 2 diabetes mellitus	5.9e-05	0.00186	CbGeAlD
Olanzapine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.21e-07	8.06e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	9.2e-07	8.06e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	9.2e-07	8.05e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.2e-07	8.05e-06	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.18e-07	8.04e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.17e-07	8.03e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.16e-07	8.02e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	9.14e-07	8.01e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.12e-07	7.99e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.11e-07	7.98e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.11e-07	7.97e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.09e-07	7.96e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.06e-07	7.93e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.03e-07	7.91e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.01e-07	7.89e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.97e-07	7.85e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.97e-07	7.85e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	8.96e-07	7.84e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.88e-07	7.77e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.86e-07	7.76e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	8.85e-07	7.75e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	8.84e-07	7.74e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.83e-07	7.73e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.77e-07	7.68e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.77e-07	7.67e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	8.74e-07	7.66e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.72e-07	7.63e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	8.67e-07	7.59e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.66e-07	7.58e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.63e-07	7.55e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	8.62e-07	7.55e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.6e-07	7.53e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.59e-07	7.52e-06	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.59e-07	7.52e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.52e-07	7.46e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.51e-07	7.45e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	8.49e-07	7.43e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.49e-07	7.43e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	8.47e-07	7.41e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—NOS3—type 2 diabetes mellitus	8.47e-07	7.41e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	8.46e-07	7.41e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.46e-07	7.4e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.45e-07	7.4e-06	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.45e-07	7.4e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	8.44e-07	7.39e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.44e-07	7.39e-06	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.43e-07	7.38e-06	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.4e-07	7.36e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.4e-07	7.35e-06	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.38e-07	7.33e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.37e-07	7.33e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.35e-07	7.31e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	8.33e-07	7.29e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.32e-07	7.29e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.32e-07	7.28e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.3e-07	7.27e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.3e-07	7.26e-06	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.29e-07	7.26e-06	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.27e-07	7.24e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.27e-07	7.24e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.24e-07	7.22e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.22e-07	7.2e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.22e-07	7.2e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.2e-07	7.18e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.18e-07	7.16e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.17e-07	7.15e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.16e-07	7.15e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.14e-07	7.13e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	8.13e-07	7.12e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	8.07e-07	7.06e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	8.06e-07	7.05e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	8.04e-07	7.04e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.04e-07	7.04e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	7.99e-07	7e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.99e-07	7e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	7.97e-07	6.98e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	7.96e-07	6.97e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.96e-07	6.97e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.95e-07	6.96e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	7.94e-07	6.96e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	7.93e-07	6.94e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.91e-07	6.93e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	7.9e-07	6.92e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	7.9e-07	6.92e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.89e-07	6.91e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.87e-07	6.89e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	7.85e-07	6.87e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.84e-07	6.87e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.83e-07	6.86e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.83e-07	6.85e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.82e-07	6.84e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	7.81e-07	6.84e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.81e-07	6.84e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.8e-07	6.83e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.78e-07	6.82e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.77e-07	6.8e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.76e-07	6.79e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	7.75e-07	6.79e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.74e-07	6.78e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	7.74e-07	6.78e-06	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.69e-07	6.73e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.68e-07	6.73e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	7.68e-07	6.73e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	7.67e-07	6.72e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.67e-07	6.72e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.66e-07	6.71e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.66e-07	6.71e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.65e-07	6.7e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.63e-07	6.68e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	7.62e-07	6.67e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	7.62e-07	6.67e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.61e-07	6.67e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.61e-07	6.66e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	7.6e-07	6.65e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	7.6e-07	6.65e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.57e-07	6.62e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.55e-07	6.61e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.53e-07	6.59e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.51e-07	6.58e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.51e-07	6.57e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.46e-07	6.54e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.42e-07	6.49e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	7.42e-07	6.49e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	7.41e-07	6.49e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.41e-07	6.49e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.4e-07	6.48e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.36e-07	6.44e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.34e-07	6.43e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	7.31e-07	6.4e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.3e-07	6.39e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.29e-07	6.38e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	7.28e-07	6.37e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.28e-07	6.37e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.25e-07	6.35e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.25e-07	6.34e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	7.24e-07	6.34e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.23e-07	6.33e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.22e-07	6.32e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.2e-07	6.3e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.19e-07	6.29e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.16e-07	6.27e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.16e-07	6.27e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.14e-07	6.25e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	7.12e-07	6.24e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.12e-07	6.23e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.1e-07	6.22e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	7.1e-07	6.22e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.09e-07	6.21e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.09e-07	6.2e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.08e-07	6.2e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.06e-07	6.19e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.05e-07	6.17e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.04e-07	6.17e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.03e-07	6.16e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.01e-07	6.14e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	6.99e-07	6.12e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	6.99e-07	6.12e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.98e-07	6.11e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.97e-07	6.11e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.95e-07	6.09e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	6.95e-07	6.09e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	6.94e-07	6.08e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.93e-07	6.07e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	6.93e-07	6.07e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	6.91e-07	6.05e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.89e-07	6.03e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	6.88e-07	6.03e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	6.83e-07	5.98e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	6.78e-07	5.94e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.78e-07	5.93e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	6.75e-07	5.91e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.68e-07	5.85e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.63e-07	5.81e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.63e-07	5.8e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.61e-07	5.79e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	6.55e-07	5.74e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	6.52e-07	5.71e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.52e-07	5.71e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.5e-07	5.7e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.5e-07	5.69e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.48e-07	5.68e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.47e-07	5.66e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.46e-07	5.66e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.46e-07	5.66e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.43e-07	5.63e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.4e-07	5.6e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.4e-07	5.6e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	6.39e-07	5.6e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.39e-07	5.6e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.38e-07	5.59e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.38e-07	5.58e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.36e-07	5.57e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6.34e-07	5.55e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.34e-07	5.55e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.28e-07	5.49e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.26e-07	5.48e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	6.23e-07	5.45e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	6.19e-07	5.42e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	6.12e-07	5.36e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.1e-07	5.34e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	6.1e-07	5.34e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	6.07e-07	5.31e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	6.03e-07	5.28e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.02e-07	5.27e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.93e-07	5.19e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	5.92e-07	5.18e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	5.92e-07	5.18e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.89e-07	5.16e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.81e-07	5.09e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.69e-07	4.98e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.66e-07	4.95e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.5e-07	4.82e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.43e-07	4.76e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.42e-07	4.74e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.41e-07	4.74e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	5.37e-07	4.7e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.31e-07	4.65e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.25e-07	4.59e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.22e-07	4.57e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.21e-07	4.56e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.08e-07	4.44e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5e-07	4.37e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.99e-07	4.37e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	4.93e-07	4.32e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.91e-07	4.3e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.9e-07	4.29e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.89e-07	4.28e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.87e-07	4.26e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.82e-07	4.22e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.81e-07	4.21e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	4.78e-07	4.18e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.61e-07	4.03e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.57e-07	4e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.57e-07	4e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.53e-07	3.97e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.52e-07	3.96e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.51e-07	3.95e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.49e-07	3.93e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.47e-07	3.91e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.45e-07	3.9e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.44e-07	3.89e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.18e-07	3.66e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.12e-07	3.61e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—type 2 diabetes mellitus	3.89e-07	3.41e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.49e-07	3.06e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.41e-07	2.99e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.21e-07	2.81e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.19e-07	2.79e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.72e-07	2.38e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.1e-07	1.84e-06	CbGpPWpGaD
